angiotensin ii has been researched along with beraprost in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okamura, T; Toda, N; Yoshida, K | 1 |
| Kimura, T; Noda, Y; Okamura, T; Toda, N | 1 |
| Chen, Y; Meng, G; Xu, X; Yang, S; Yao, W; Zhang, W; Zhu, H | 1 |
3 other study(ies) available for angiotensin ii and beraprost
| Article | Year |
|---|---|
Suppression by methylene blue of prostaglandin I2 synthesis in isolated dog renal arteries.
Topics: Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Dinoprostone; Dogs; Epoprostenol; Female; In Vitro Techniques; Male; Methylene Blue; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Renal Artery; Thromboxane B2; Vasoconstriction | 1990 |
Mechanisms of relaxation induced by angiotensin II in isolated canine and human uterine arteries.
Topics: Adult; Aged; Angiotensin II; Animals; Arteries; Aspirin; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Female; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Platelet Aggregation Inhibitors; Tranylcypromine; Uterus; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2001 |
Prostacyclin analogue beraprost inhibits cardiac fibroblast proliferation depending on prostacyclin receptor activation through a TGF β-Smad signal pathway.
Topics: Angiotensin II; Animals; Base Sequence; Cell Proliferation; DNA Primers; Epoprostenol; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptors, Epoprostenol; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2014 |